| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Debt Relief > Can You Believe Those Credit Card Companies? |
|
Top Articles - Can You Believe Those Credit Card Companies?
When the people that run credit card companies (CCCs) die, I think they are going to be in big trouble. I was watching TV and According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product saw an interview with a credit card executive. She was asked if CCCs want to have customers carry a balance forward on their c ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ards. She said no way, they want customers to pay off their cards. That way the companies know they get their money. What a l lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. oad of crap! CCCs do everything they can to make us carry a balance from month to month. That way we have to pay all their cra here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe y interest rates and fees. I wrote before about how they hire experts to study who is likely to carry a balance from month to d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro month but not go bankrupt. They then market to those people. It is unlikely the people who run CCCs are just plain evil. It i ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc s likely though that they check their conscience at the door before entering work. There was a movie called “The Corporation” easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi hat showed how average and ordinarily nice people can turn into mean cutthroat people at work. Eventually they're willing to d nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically o everything and almost anything they can to make money for the corporation. They gave little or no thought to the millions of and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ lives that are being ruined in the process. I, being a business person myself, strongly see the need for a company to make a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi profit. There is a line however that is being crossed by some companies. When you see the profits of these CCCs it will blow y ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a our mind. In 2004 cardweb reported the industry made 30.4 BILLION dollars. Up from 20 billion in 2000. I'll let you figure out dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod how much money that is a day. I don’t care what you do, when you can make more money than over 140 countries do in a year's cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin GDP something is wrong. What can you do, cut up your credit card? Is that too drastic for you? Then write your politicians, i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen will take a lot of letters over a fair bit of time but that will force them to change legislation and make CCCs operate more t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ethically. The last way is to pay off your credit card, in full, before the free interest period is up. I have carried a bala ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nce forward twice in my life, once I thought “heck I will have the money in two days, how much can it cost?” It was $148.60, f y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products r two days. Well that’s when I did some research on how it all worked and realized the scam. The second time I simply forgot w . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hat day it was, now it is on auto-payment. Figure it out folks CCCs are not here for your benefit. If you cannot completely p elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ay off your balance every month then do not use credit cards or learn to like helping these companies earn even bigger profits tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Superior Customer Service: Seven Strategies for Success Investment Strategy: Contrarian Investing 101 The Ups and Downs of Dedicated Server Hosting
|